Atara Biotherapeutics (ATRA) Return on Equity [ROE] (2014 - 2024)
Atara Biotherapeutics' Return on Equity [ROE] was -8768.28% in FY2024, down 8523.78 percentage points from -244.50% in FY2023.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Return on Equity [ROE] (2014 - 2024) Analysis & Trends
From FY2014 onward, Atara Biotherapeutics has reported Return on Equity [ROE] for 11 years.
- Return on Equity [ROE] has now declined for four consecutive years, with a five-year change of -8675.90 percentage points (FY2019 to FY2024).
- The FY2024 figure marks the lowest annual Return on Equity [ROE] in data going back to FY2014.
- Per Business Quant data, Return on Equity [ROE] in earlier years was -244.50% in FY2023 (-132.11 pp), -112.39% in FY2022 (-20.71 pp), -91.69% in FY2021 (-10.26 pp) and -81.43% in FY2020 (+10.95 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Atara Biotherapeutics | 142.51 Mn | 132.61 Mn | 439,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -50,510.73% |
| Dec 31, 2023 | -1,141.18% |
| Jun 30, 2023 | -841.11% |
| Mar 31, 2023 | -224.39% |
| Dec 31, 2022 | -145.53% |
| Sep 30, 2022 | -111.15% |
| Jun 30, 2022 | -102.80% |
| Mar 31, 2022 | -138.87% |
| Dec 31, 2021 | -115.35% |
| Sep 30, 2021 | -102.26% |
| Jun 30, 2021 | -87.00% |
| Mar 31, 2021 | -72.31% |
| Dec 31, 2020 | -75.42% |
| Sep 30, 2020 | -82.99% |
| Jun 30, 2020 | -95.45% |
| Mar 31, 2020 | -110.16% |
| Dec 31, 2019 | -96.06% |
| Sep 30, 2019 | -106.81% |
| Jun 30, 2019 | -108.71% |
| Mar 31, 2019 | -82.53% |
API Access
Atara Biotherapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();